通过基因优先排序来确定精神分裂症的药物标
Julia Kraft1,2,3, Alice Braun1,2,3, Swapnil Awasthi1,2,3
1Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Translational psychiatry
|February 4, 2026
概括
这项研究使用先进的基因组方法确定了101个与精神分裂症相关的基因. 这些基因为药物重新定位和开发提供了新的点,有可能彻底改变精神分裂症治疗.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 全基因组关联研究 (GWASes) 已经确定了许多精神分裂症风险位置.
- 以前的基因优先级方法往往忽略了全基因组信息,限制了准确性.
研究的目的:
- 为了全面识别和优先考虑涉及精神分裂症病因的基因.
- 通过药物改用和开发,发现精神分裂症的新型治疗点.
主要方法:
- 应用了基于位置和全基因组方法的组合,对大型GWAS数据集进行了应用.
- 综合精细映射,基于距离和基于基因的关联测试 (PoPS,MAGMA).
- 基于现有的药物向,预测的药物可用性和模型中的可测性来优先考虑基因.
主要成果:
- 列出了101个高度自信的精神分裂症相关基因的优先清单.
- 确定了15个基因,这些基因是现有药物向的,其中7个基因尚未在临床上测试精神疾病.
- 突出显示了7个基因,尽管缺乏当前的小分子抑制剂,但预计可以使用药物.
- 在与成GWAS共享的位置中发现了2个可用药物的基因,这表明了共享的机制.
结论:
- 精心策划的101个基因列表为了解精神分裂症病原体提供了宝贵的资源.
- 针对这些优先的基因为开发新型精神分裂症疗法提供了一个有希望的途径.
- 在成模型中探索共享基因可能会加速两种疾病的药物开发.
相关概念视频
Schizophrenia
980
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
980
Biological Causes of Schizophrenia
633
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
633
Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
Psychological and Sociocultural Causes of Schizophrenia
626
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
626
Negative and Cognitive Symptoms of Schizophrenia
584
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
584
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.0K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.0K


